Clostridium butyricum capsules

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

Each capsule of this product contains no less than 6.3×106 (6 is a superscript) CFU of Clostridium butyricum. The auxiliary materials are starch and glucose.

This product is a capsule, the contents are white or off-white powder, with grayish yellow spots, slightly special smell, sweet taste.

Various gastrointestinal symptoms caused by intestinal flora disorders and related acute and chronic diarrhea and indigestion, etc.

Oral administration: Adults, 3 capsules at a time, 2 times a day. For acute diarrhea, the course of treatment is 3 to 7 days; for chronic diarrhea, the course of treatment is 14 to 21 days.

No adverse reactions were observed in clinical studies.

It is contraindicated for those with a history of allergy to microecological preparations.

Precautions for children: Children under 12 years old should take 1 tablet 3 times a day; infants and young children should take the medicine according to the doctor's instructions (powder can be poured out and swallowed with warm water). Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

1. Clostridium butyricum is sensitive to ampicillin, cefazolin, cefuroxime, tetracycline, chloramphenicol, furazolidone (Furazolidone), co-trimoxazole and norfloxacin. Taking them at the same time with these antibacterial drugs may weaken their efficacy and should be taken separately (2 to 3 hours apart). 2. If used at the same time with other drugs, drug interactions may occur. Please consult a doctor or pharmacist for details.

Store in a dry place at room temperature.

Each capsule contains 420 mg, and contains no less than 1.5x107 (7 is a superscript) CFU/g of live Clostridium butyricum.

24 months

Qingdao Eastsea Pharmaceutical Co., Ltd.

• Founded in:

  2003-08-08

• Address:

  No. 1377, Jiaozhouwan West Road, Huangdao District, Qingdao

• Tax NO.:

  91370211750444874X

• Registered Funds:

  60 million yuan

• Website:

  Log in to view

• Email:

  Log in to view